Ζωής

In both Alzheimer’s disease (AD) and glioma, many molecular processes are disrupted, but the precise underlying mechanisms remain largely unknown. Recent advances in proteomic techniques have made it possible to study molecular complexity of these disorders in more detail and have revealed that distinct disease subtypes may exist in these disorders that each require subtype-specific therapy.